Zobrazeno 1 - 10
of 19
pro vyhledávání: '"59"'
Publikováno v:
Transplantation. 78(8)
Background. Studies have provided conflicting results as to the protective role of calcium channel blockers (CCB) in cyclosporine-treated patients with regard to blood pressure control and preservation of renal graft function. Lacidipine is a dihydro
Publikováno v:
Transplantation. 73(9)
reduce the kidney shortage: kidneys from non-heart beating donors.Transplantation 1998; 65: 1465.8. Koostra G, Deamen JHC, Oomen APA. Categories of non-heart beatingkidney donors. Transplant Proc 1997; 27: 2893.9. Hancock WW, Whitley WD, Tullius SG,
Autor:
Gurmukh Singh, Thomas R. Hakala, Rodney J. Taylor, T. E. Starzl, Bruce S. Rabin, Monica Liebert, Rosenthal Jt, E Merrall
Publikováno v:
Transplantation. 36:200-202
Improved allograft survival has been observed in patients treated with cyclosporine, a new immunosuppressive agent (1, 2). One problem in the management of patients treated with cyclosporine is a drug-associated nephrotoxicity (2, 3) that can be diff
Autor:
Nicolae Leca, James D. Perkins, Abdul Moiz, Raimund Pichler, Connie L. Davis, Jolanta Kowalewska, Janna Huskey
Publikováno v:
Transplantation. 100(10)
Renal biopsy has been proposed to determine the cause or reversibility of renal failure for patients with end-stage liver disease and may be useful in the kidney allocation. Nevertheless, little data exist to validate the usefulness of kidney biopsie
Autor:
Denyse Breault, J Nogueira, Debora A. Evans, Stephen C. Jacobs, Matthew R. Weir, Stephen T. Bartlett, David K. Klassen, Mark E. Cooper
Publikováno v:
Transplantation. 90:993-999
Little is known about the long-term outcomes of obese living kidney donors (OLKDs). We undertook this study to describe renal outcomes of OLKDs several years after donation.We invited 101 OLKDs for follow-up health evaluation.Thirty-six subjects (35.
Autor:
Brian J. Nankivell, Philip J. O'Connell, Caroline L.-S. Fung, Moses Wavamunno, Jeremy R. Chapman, M. Vitalone
Publikováno v:
Transplantation. 89:537-547
Background. Tubulointerstitial damage (TID) is a key feature of chronic kidney transplant failure; however, the associated gene expression changes are poorly defined. Methods. This pilot study used RNA from 59 protocol kidney transplant biopsies at i
Autor:
Ramasamy Bakthavatsalam, Connie L. Davis, Jorge D. Reyes, Jeffrey B. Halldorson, Nicolae Leca, Paolo R. Salvalaggio, Elizabeth A. Kendrick, Raimund Pichler
Publikováno v:
Transplantation. 89:208-214
BACKGROUND Pediatric en-bloc kidney transplantation into adult recipients is an accepted technique to expand the donor pool. Concerns about adequate "nephron dosing" have traditionally favored placing these kidneys into smaller recipients. METHODS We
Autor:
Shahid M. Khan, Joshua N. Daniel, Billie Fyfe, Nedjema Sustento-Riodeca, Michael J. Moritz, M. S. A. Kumar, Muhammad I. Saeed, Aparna Kumar, Michael Heifets
Publikováno v:
Transplantation. 81:832-839
Background. Chronic steroid therapy in spite of myriad side effects is widely used in kidney transplantation. This prospective controlled study evaluated safety and efficacy of steroid withdrawal at 2 days in kidney recipients monitored by surveillan
Autor:
Donna Phelan, T. Mohanakumar, Samuel So, Martin D. Jendrisak, Tina M. Rush, Sheila M. Michalski, Douglas W. Hanto, Christopher S. McCullough
Publikováno v:
Transplantation. 57:377-384
Improved cadaver kidney allograft survival rates, shorter duration of acute tubular necrosis, and a reduction in the incidence of rejection have been achieved using "quadruple sequential therapy"--AZA, prednisone, and antilymphocyte globulin (ALG) in
Publikováno v:
Transplantation. 91(12)
Background. Improved early kidney transplant outcomes limit the contemporary utility of standard clinical endpoints. Quantifying the relationship of renal function at 1 year after transplant with subsequent clinical outcomes and healthcare costs may